Long-term preventive and acute treatment of migraine with rimegepant improves health related quality of life

被引:0
|
作者
Pavlovic, J. M. [1 ]
Turner, I. M. [2 ]
Winner, P. [3 ]
Lipton, R. B. [4 ]
Litalien, G. J. [5 ]
Jensen, C. M. [6 ]
Thiry, A. C. [6 ]
Kamen, L. [6 ]
Coric, V [5 ]
Croop, R. [5 ]
机构
[1] Albert Einstein Coll Med, Montefiore Headache Ctr, Bronx, NY 10467 USA
[2] Isl Neurol Associates, Plainview, NY USA
[3] Palm Beach Neurol, W Palm Beach, FL USA
[4] Albert Einstein Coll Med, Bronx, NY 10467 USA
[5] Biohaven Pharmaceut Holding Co Ltd, New Haven, CT USA
[6] Biohaven Pharmaceut, New Haven, CT USA
来源
HEADACHE | 2022年 / 62卷
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P-128
引用
收藏
页码:112 / 113
页数:2
相关论文
共 50 条
  • [1] Long-Term Preventive and Acute Treatment of Migraine With Rimegepant Improves Health Related Quality of Life
    Pavlovic, Jelena
    Turner, Ira
    Winner, Paul
    Lipton, Richard
    L'Italien, Gilbert
    Jensen, Christopher
    Thiry, Alexandra
    Kamen, Lisa
    Croop, Robert
    [J]. NEUROLOGY, 2023, 100 (17)
  • [2] Acute Treatment of Migraine With Rimegepant Improves Health Related Quality of Life in Adults With a History of Triptan Treatment Failure: Results from a Long-Term, Open-Label Safety Study
    Turner, I.
    Winner, P.
    Lipton, R. B.
    Jensen, C. M.
    L'Italien, G.
    Thiry, A.
    Lovegren, M.
    Conway, C. M.
    Coric, V.
    Croop, R.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 101 - 101
  • [3] Acute treatment of migraine with rimegepant improves health related quality of life in adults with a history of triptan treatment failure: Results from a long-term, open-label safety study
    Turner, I. M.
    Winner, P. K.
    Lipton, R. B.
    Jensen, C. M.
    L'Italien, G. J.
    Thiry, A. C.
    Lovegren, M.
    Conway, C. M.
    Coric, V
    Croop, R.
    [J]. HEADACHE, 2021, 61 : 108 - 109
  • [4] Acute Treatment of Migraine with Rimegepant Improves Health Related Quality of Life in Adults With a History of Triptan Treatment Failure: Results from a Long-Term, Open-Label Safety Study
    Turner, Ira
    Winner, Paul
    Lipton, Richard
    Jensen, Christopher
    L'Italien, Gilbert
    Thiry, Alexandra
    Lovegren, Meghan
    Conway, Charles
    Coric, Vlad
    Croop, Robert
    [J]. NEUROLOGY, 2021, 96 (15)
  • [5] Acute Treatment of Migraine With Rimegepant Improves Health Related Quality of Life in Adults With a History of Triptan Treatment Failure: Results from a Long-Term, Open-Label Safety Study
    Turner, I.
    Winner, P.
    Lipton, R. B.
    Jensen, C. M.
    L'Italien, G.
    Thiry, A.
    Lovegren, M.
    Conway, C. M.
    Coric, V.
    Croop, R.
    [J]. CEPHALALGIA, 2021, 41 (1_SUPPL) : 150 - 150
  • [6] Acute Treatment of Migraine with Oral Rimegepant 75 Mg Improves Health Related Quality of Life: Results from a Long-term, Open-label Safety Study (BHV3000-201)
    Harris, L.
    L'Italien, G. J.
    Croop, R.
    Stock, E. G.
    Thiry, A. C.
    Lovegren, M.
    Jensen, C. M.
    Coric, V
    Lipton, R. B.
    [J]. HEADACHE, 2020, 60 : 97 - 98
  • [7] Acute Treatment of Migraine with Oral Rimegepant 75 mg Improves Health Related Quality of Life: Results from a Long-Term, Open-Label Safety Study (BHV3000-201)
    Harris, Linda
    L'Italien, Gilbert
    Croop, Robert
    Stock, Elyse
    Thiry, Alexandra
    Cowrie, Kate
    Lovegren, Meghan
    Jensen, Christopher
    Coric, Vladimir
    Lipton, Richard
    [J]. NEUROLOGY, 2020, 94 (15)
  • [8] Rimegepant: A Review in the Acute Treatment and Preventive Treatment of Migraine
    Hannah A. Blair
    [J]. CNS Drugs, 2023, 37 : 255 - 265
  • [9] Rimegepant: A Review in the Acute Treatment and Preventive Treatment of Migraine
    Blair, Hannah A.
    [J]. CNS DRUGS, 2023, 37 (03) : 255 - 265
  • [10] Acute Migraine Treatment with Rimegepant 75mg and Health Related Quality of Life in Migraine: Results from a Long-Term, Open-Label Safety Study (BHV-3000-201)
    Litalien, Gilbert
    Croop, Robert
    Stock, Elyse
    Thiry, Alexandra
    Lovegren, Meghan
    Jensen, Chris
    Cowie, Kathryn
    Coric, Vladimir
    Lipton, Richard
    [J]. CEPHALALGIA, 2019, 39 (1_SUPPL) : 393 - 393